empagliflozin semaglutide Ozempic outperforms another diabetes drug for reducing stroke risk Scripts for GLP-1, SGLT2 Drugs

Consistency in taking the medication is key to achieving the desired effects

Clinical trials such as the STEP program (semaglutide) and SURMOUNT trials (tirzepatide) demonstrate that patients typically experience reduced caloric intake, with many reporting decreased interest in food and smaller portion sizes

By changing how the brain uses chemicals like dopamine, these drugs may make cravings weaker and easier to ignore

The breakfasts in this guide are designed specifically for the challenges of GLP-1 medicationsthey're high in protein to preserve muscle, moderate in fat to minimize nausea, and practical enough to execute even when you feel terrible

In addition, medication side effects like nausea, vomiting, and diarrhea can lead to fluid loss